The coming week has a subdued forecast when it comes to initial public offerings with only two small and medium enterprises opening their IPOs. There are no mainboard IPOs.
The two SME IPOs, to be launched by Accretion Pharmaceuticals Ltd. and Integrity Infrabuild Developers Ltd., will open on Tuesday and Wednesday, respectively.
The IPO market has displayed caution amid the tensions between India and Pakistan, which also caused the stock market to end in the red on Friday.
Integrity Infrabuild Developers IPO
IPO opens: May 13
IPO closes: May 15
Issue size: 12 lakh shares (aggregating up to Rs 12 crore)
Fresh issue: Rs 12 crore
Tentative allotment date: May 16
Tentative Listing date: May 19
Face value: Rs 10 per share
Lot size: 1,200 shares
Issue type: Fixed Price IPO
Listing platform: BSE SME
About Integrity Infrabuild Developers
Integrity Infrabuild Developers Ltd., a class-A civil contractor licensed by the government of Gujarat, focuses on executing government construction projects within the state.
To further its reach in Gujarat's construction industry, the company frequently utilises subcontracting.
As of March 31, 2025, Integrity Infrabuild holds ongoing contracts worth a total of Rs 205.98 crore. Out of this total, Rs 42.91 crore worth of work has been completed, leaving a substantial order book valued at Rs 163.07 crore.
Accretion Pharmaceuticals IPO
IPO opens: May 14
IPO closes: May 16
Issue size: 29,46,000 shares (aggregating up to Rs 29.75 Crore)
Fresh issue: Rs 29.75 Crore
Tentative allotment date: May 19
Tentative Listing date: May 21
Face value: Rs 10 per share
Lot size: 1,200 shares
Issue type: Book building IPO
Listing platform: NSE SME
About Accretion Pharmaceuticals
Accretion Pharmaceuticals Ltd. is a pharmaceutical company involved in the production and distribution of various healthcare products, including tablets and capsules.
In addition to its own product line, the company provides contract manufacturing services. Accretion Pharmaceuticals' manufacturing and marketing activities cover a broad range of pharmaceutical formulations, such as tablets, capsules, oral liquids, external preparations (ointments, creams, gels, lotions, medicated shampoos, mouthwashes, dusting powders), and oral powders (in sachet and dry syrup forms).
RECOMMENDED FOR YOU

OpenAI Partners With Apple Supplier Luxshare To Develop AI Device: All You Need To Know


UK And India Partner To Develop Quantum Technology Value Chain


Adani Power To Develop 2,400 Megwatt Thermal Power Project In Bihar


NASA, IBM Develop 'Surya': Here's How Advanced AI Model Can Protect From Solar Storms
